Please assess the completion status of the following clinical trial:

Trial Title: Treatment and Prognosis of Neurogenic Orthostatic Hypotension : A Prospective Randomized Study

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~* age \>=18 patients who complained of dizziness~* Orthostatic hypotension after 3-minute standing (systolic blood pressure drop \>=20 or diastolic blood pressure drop \>=10~Exclusion Criteria:~* Drug-induced hypotension, if necessary, evaluate patient after discontinuing the causative drug for one month~* Heart failure or Chronic renal failure~* Patients who cannot or do not want to write questionaires.~* Poor drug compliance

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: t

Study Arms:
- Midodrine (Type: EXPERIMENTAL): Start midodrine 2.5mg bid, and then dose up to 5mg bid after one month if necessary.
- Pyridostigmine (Type: EXPERIMENTAL): Start Pyridostigmine 30mg bid, and then dose up to 60mg bid after one month if necessary.
- Midodrine + Pyridostigmine (Type: EXPERIMENTAL): Start midodrine 2.5mg bid+ Pyridostigmine 30mg bid, and then dose up to midodrine 5mg bid+ Pyridostigmine 60mg bid after one month if necessary.

Based on this trial design, predict the completion outcome and termination type (if applicable).